Document is current
Any future updates will be listed below
-
Authors
Ribi, Karin http://orcid.org/0000-0003-4724-1197
Thürlimann, Beat
Schär, Corinne
Dietrich, Daniel
Cathomas, Richard
Zürrer-Härdi, Ursina
von Briel, Thomas
Anchisi, Sandro
Bohanes, Pierre
Blum, Veronika
von Burg, Philippe
Mannhart, Meinrad
Caspar, Clemens B.
von Moos, Roger
Mark, Michael
-
Funding
Funding for this research was provided by:
Amgen (Not applicable)
Swiss State Secretary for Education, Research and Innovation (Not applicable)
Swiss Cancer Research Foundation (Not applicable)
Swiss Cancer League (Not applicable)
- License Information
-
More Information
Article History
Received: 9 October 2020
Accepted: 12 February 2021
First Online: 19 February 2021
Ethics approval and consent to participate
: All patients provided written informed consent before participating. The study was approved by the cantonal ethics committee of Zurich BASEC 2017–01337 for all participating sites.
: Not applicable.
: KR has no conflict of interest to declare.BT holds stock of Novartis and Roche, and has received consultation honoraria from Amgen, AstraZeneca, Novartis and Roche.CS has no conflict of interest to declare.DD has no conflict of interest to declare.RC has participated in advisory boards for Amgen, Astellas, AstraZeneca, Bayer, BMS, Janssen, MSD, Novartis, Pfizer and Roche; and has received speaker honoraria from Astellas, BMS, Debiopharm and Janssen.UZH declares travel support for medical conference support: Gilead, Lilly, Pfizer, Bayer, Celgene, Merk MSD.TvB has no conflict of interest to declare.SA, has participated in advisory boards for Janssen-Cilag, Lilly and Novartis, and received congress/travel sponsoring from Amgen.PB has no conflict of interest to declare.VB has no conflict of interest to declare.PvB has no conflict of interest to declare.MM has no conflict of interest to declare.CC has no conflict of interest to declare.RvM has participated in advisory boards for Amgen, Bayer, Novartis and Roche.MM has participated in advisory boards for BMS, MSD, AstraZeneca, Roche and Takeda; and has received an institutional research grant from AstraZeneca.
